Valeant Pharma (VRX) Receives Subpoena from California Department of Insurance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Complete Donald Trump Stock Impact Guide
November 9, 2016 12:03 PM ESTDonald Trump's victory not only shocked the world but shocked the market. Below are all the sectors and stocks being impacted by his victory:
Biotech (Positive): Trump is viewed as less onerous than Clinton on drug pricing.
Gilead Sciences (NASDAQ: GILD) +4.5%Celgene (NASDAQ: CELG) +8.5%XBI (NYSE: XBI) is up 7%IBB (NYSE: IBB) is up 6.6%Alexion Pharmaceuticals (NASDAQ: ALXN)... MoreValeant Pharma (VRX) Shares See Early Bounce Higher
November 9, 2016 8:56 AM ESTValeant Pharma (NYSE: VRX) shares are ticking higher early following a 22 percent drop on Monday amid weak Q3 results and cut outlook. The stock is up well over 2 percent ahead of the opening bell, going against broader market pressure.
... More